Edvard Abel

3.5k total citations
13 papers, 236 citations indexed

About

Edvard Abel is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology and Oncology. According to data from OpenAlex, Edvard Abel has authored 13 papers receiving a total of 236 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Otorhinolaryngology and 6 papers in Oncology. Recurrent topics in Edvard Abel's work include Head and Neck Cancer Studies (6 papers), Oral health in cancer treatment (3 papers) and Brain Metastases and Treatment (3 papers). Edvard Abel is often cited by papers focused on Head and Neck Cancer Studies (6 papers), Oral health in cancer treatment (3 papers) and Brain Metastases and Treatment (3 papers). Edvard Abel collaborates with scholars based in Sweden, Denmark and United Kingdom. Edvard Abel's co-authors include Jan Nyman, Thomas Björk‐Eriksson, Eva Hammerlid, Ewa Silander, Eva Brun, Lalle Hammarstedt‐Nordenvall, Signe Friesland, Henrik Carlsson, Per Nilsson and Helena Sjödin and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Digestive Diseases and Sciences.

In The Last Decade

Edvard Abel

11 papers receiving 235 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edvard Abel Sweden	8	128	115	105	75	34	13	236
Gopal Bajaj United States	11	157 1.2×	127 1.1×	88 0.8×	129 1.7×	24 0.7×	21	286
Nachi Palaniappan United Kingdom	8	218 1.7×	87 0.8×	73 0.7×	171 2.3×	21 0.6×	16	314
Monali Swain India	8	152 1.2×	77 0.7×	64 0.6×	84 1.1×	15 0.4×	33	236
Kate Garcez United Kingdom	11	121 0.9×	94 0.8×	75 0.7×	68 0.9×	17 0.5×	24	234
Muhammad Shahid Iqbal United Kingdom	11	137 1.1×	117 1.0×	116 1.1×	120 1.6×	18 0.5×	45	289
Sandro Tonoli Italy	8	215 1.7×	232 2.0×	102 1.0×	148 2.0×	43 1.3×	22	394
Francisco Valcárcel Spain	10	48 0.4×	135 1.2×	140 1.3×	102 1.4×	37 1.1×	20	324
L. Dixon United Kingdom	9	80 0.6×	178 1.5×	165 1.6×	259 3.5×	19 0.6×	15	349
T. Nwizu United States	11	276 2.2×	140 1.2×	109 1.0×	167 2.2×	41 1.2×	23	340
B.S. Glisson United States	7	258 2.0×	166 1.4×	169 1.6×	173 2.3×	47 1.4×	10	357

Countries citing papers authored by Edvard Abel

Since Specialization

Citations

This map shows the geographic impact of Edvard Abel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edvard Abel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edvard Abel more than expected).

Fields of papers citing papers by Edvard Abel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edvard Abel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edvard Abel. The network helps show where Edvard Abel may publish in the future.

Co-authorship network of co-authors of Edvard Abel

This figure shows the co-authorship network connecting the top 25 collaborators of Edvard Abel. A scholar is included among the top collaborators of Edvard Abel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edvard Abel. Edvard Abel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Gebre‐Medhin, Maria, Gabriel Adrian, Per Engström, et al.. (2025). Chemoradiation therapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer—Mature Results of the ARTSCAN III Trial. International Journal of Radiation Oncology*Biology*Physics. 123(3). 681–690.

Ny, Lars, Henrik Fagman, Johan Botling, et al.. (2025). Feasibility and outcome of genomics-guided treatment selection in advanced cancer – the MEGALiT explorative clinical trial. Acta Oncologica. 64. 742–750.

Rohrberg, Kristoffer Staal, Zsuzsanna Pápai, Rikke Løvendahl Eefsen, et al.. (2024). 19-BI-1808-01, a phase 1/2a clinical trial of BI-1808, a tumor necrosis factor receptor 2 (TNFR2) blocker/depleter with or without pembrolizumab.. Journal of Clinical Oncology. 42(16_suppl). 2641–2641. 1 indexed citations

Taskén, Kjetil, Edvard Abel, Katarina Steen Carlsson, et al.. (2024). Single point of entry to the European precision cancer medicine trial network PRIME-ROSE.. Journal of Clinical Oncology. 42(16_suppl). e23024–e23024. 2 indexed citations

Abel, Edvard, Ewa Silander, Fredrik Nordström, et al.. (2022). Fatigue in Patients With Head and Neck Cancer Treated With Radiation Therapy: A Prospective Study of Patient-Reported Outcomes and Their Association With Radiation Dose to the Cerebellum. Advances in Radiation Oncology. 7(5). 100960–100960. 11 indexed citations

Gebre‐Medhin, Maria, Eva Brun, Per Engström, et al.. (2020). ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer. Journal of Clinical Oncology. 39(1). 38–47. 98 indexed citations

Abel, Edvard, Ewa Silander, Jan Nyman, Thomas Björk‐Eriksson, & Eva Hammerlid. (2019). Long-Term Aspects of Quality of Life in Head and Neck Cancer Patients Treated With Intensity Modulated Radiation Therapy: A 5-Year Longitudinal Follow-up and Comparison with a Normal Population Cohort. Advances in Radiation Oncology. 5(1). 101–110. 23 indexed citations

Olsson, Caroline, Tufve Nyholm, Elinore Wieslander, et al.. (2019). Initial experience with introducing national guidelines for CT- and MRI-based delineation of organs at risk in radiotherapy. Physics and Imaging in Radiation Oncology. 11. 88–91. 5 indexed citations

Abel, Edvard, Ewa Silander, Jan Nyman, et al.. (2017). Impact on quality of life of IMRT versus 3-D conformal radiation therapy in head and neck cancer patients: A case control study. Advances in Radiation Oncology. 2(3). 346–353. 29 indexed citations

10.

Nyman, Jan, Eva Hammerlid, Erik Holmberg, et al.. (2017). Results of preoperative chemoradiotherapy for patients with advanced cancer of the nasal cavity and paranasal sinuses. Acta Oto-Laryngologica. 137(12). 1292–1300. 19 indexed citations

11.

Kalm, Marie, Edvard Abel, Pontus Wasling, et al.. (2014). Neurochemical Evidence of Potential Neurotoxicity After Prophylactic Cranial Irradiation. International Journal of Radiation Oncology*Biology*Physics. 89(3). 607–614. 16 indexed citations

12.

Grønberg, Bjørn Henning, Tudor–Eliade Ciuleanu, Øystein Fløtten, et al.. (2012). A placebo-controlled, randomized phase II study of maintenance enzastaurin following whole brain radiation therapy in the treatment of brain metastases from lung cancer. Lung Cancer. 78(1). 63–69. 22 indexed citations

13.

Abel, Edvard, et al.. (2005). Early Disturbance of Microvascular Function Precedes Chemotherapy-Induced Intestinal Injury. Digestive Diseases and Sciences. 50(9). 1729–1733. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact